-
Jina Embeddings v2: Handling Long Documents Made Easy
How Jina Embeddings v2 simplifies long-document NLP with 8192-token support? Learn its features, benefits, and real-world applications.
seematiwari . 27 Jan, 2025
-
Hewlett Packard Enterprise in association with Imarticus Learning presents LIVE WEBINAR on “NEXT BEST OFFER”
Imarticus Learning and Hewlett Packard Enterprise (HPE) present to you a joint webinar on the ‘Next Best Offer’ Analytics.
Analytics Vidhya 23 Feb, 2016 -
Altman’s Steve Jobs Moment as OpenAI CEO
Timeline of events from the excitement of DevDay and GPT-5 revelations - to the abrupt removal of OpenAI's CEO, Sam Altman.
NISHANT TIWARI 04 Jun, 2025
-
Build a Multimodal Agent for Product Ingredient Analysis
Learn how to build a smarter, faster Product Ingredient Analyzer using Gemini 2.0, Phidata, and Tavily Web Search.
Tarun R Jain 18 Mar, 2025
-
A Comprehensive Guide to Smallpond
Explore the features, components, and applications of DeepSeek AI's Smallpond framework, and also learn how to use it.
Kabyik Kayal 27 Mar, 2025
-
Fraud Analyst – Gurgaon (6-8 years of experience)
Gurgaon is looking for Fraud Analyst with experience in SAS, SQL, Banking domain etc
deepak 25 Nov, 2015 -
Capgemini and AWS Strengthen Ties for Widespread Generative AI Adoption
Capgemini and Amazon Web Services (AWS) have extended their strategic collaboration, accelerating the adoption of generative AI solutions.
K.C. Sabreena Basheer 18 Jan, 2024
-
Preference Fine-Tuning LFM 2 Using DPO
Learn how to fine-tune Liquid Foundation Models (LFM 2) using Direct Preference Optimization for efficient, edge-ready small language models.
Shaik Hamzah 07 Jan, 2026
-
This is How Fireworks.ai is Democratizing Generative AI for Developers
Explore Fireworks.ai, an innovative startup revolutionizing Generative AI. Fine-tune models, integrate API, and unlock new possibilities.
Nitika Sharma 27 Mar, 2024
-
Elon Musk’s Neuralink Confronts First Human Trial Malfunction
Neuralink's recent brain implant malfunction prompts swift rectification, raising concerns for FDA approval & future trials.
Aayush Tyagi 10 May, 2024
